Research Advances in Mechanisms for Combination Therapy with Stereotactic Body Radiation Therapy and Immunotherapy

Li Jiaqi,Wang Hao,Yang Ruijie

DOI: https://doi.org/10.3760/cma.j.issn.1004-4221.2017.12.023

2017-01-01

Abstract:In recent years,a large number of pre-clinical and clinical investigations have indicated that stereotactic body radiation therapy(SBRT)can not only kill cancer cells directly,but also induce the immunogenic death of cancer cells through releasing numerous tumor-associated antigens and damage-associated molecular patterns to form in situ tumor vaccine. CD8(+)T cells in lymph nodes are cross-sensitized by activated antigen-presenting cells. SBRT initiates local and systemic anti-tumor immune response. Moreover, SBRT can induce the abscopal effect if combined with immunotherapy. In addition, SBRT improves the microenvironment for tumor immunosuppression and enhances the sensitivity of tumors to immunotherapy. This article reviews the research advances in the synergistic mechanisms for combination therapy with SBRT and immunotherapy.